Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingFeb 12, 2025Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0216-2025Class IIOngoingFeb 12, 2025Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0215-2025Class IIOngoingFeb 12, 2025Timolol Maleate Ophthalmic Solution USPDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.FDC Limited · D-0214-2025Class IIOngoingFeb 5, 2025InflectracGMP Deviations: Product intended for quarantine was inadvertently distributed.McKesson · D-0213-2025Class IITerminatedFeb 5, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limitThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0212-2025Class IOngoingFeb 5, 2025PrografFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsulesAstellas Pharma US Inc. · D-0211-2025Class IOngoingFeb 5, 2025Astagraf XLFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsulesAstellas Pharma US Inc. · D-0210-2025Class IIITerminatedFeb 5, 2025BADGER 50Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.The W.S. Badger Company, Inc. · D-0209-2025Class IIICompletedJan 29, 2025Venlafaxine Extended-Release TabletsFailed Tablet/Capsule Specifications: Missing tab ID on either side of the tabletAppco Pharma LLC · D-0208-2025Class IOngoingJan 29, 2025FOUZEE SugarLin HERBAL FORMULA capsulesMarketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburideShoppers- Plaza · D-0207-2025Class IIOngoingJan 29, 2025First Aid Beauty Ultra Repair CreamCGMP Deviations; product intended for quarantine was inadvertently distributedFirst Aid Beauty Ltd · D-0206-2025Class IIOngoingJan 29, 2025Kissable Diabetics Foot CreamCGMP Deviations: lack of adequate release testing.Brands International Corporation · D-0205-2025Class IITerminatedJan 22, 2025Cardura XLFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Viatris Inc · D-0204-2025Class IITerminatedJan 22, 2025Cardura XLFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Viatris Inc · D-0203-2025Class IITerminatedJan 22, 2025glipiZIDEFailed Dissolution Specifications:Amerisource Health Services LLC · D-0202-2025Class IIOngoingJan 22, 2025Clobazam TabletsPresence of Foreign Tablets/CapsulesAmerisource Health Services LLC · D-0201-2025Class IOngoingJan 22, 2025Systane Lubricant Eye DropsNon-SterilityAlcon Research LLC · D-0200-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 50 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0199-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0198-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0197-2025Class IIIOngoingJan 22, 2025Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0196-2025Class IIIOngoingJan 22, 2025AcetaminophenLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0195-2025Class IIIOngoingJan 22, 2025Acetaminophen Regular StrengthLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0194-2025Class IIIOngoingJan 22, 2025Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0193-2025Class IITerminatedJan 15, 2025Metformin Hydrochloride Extended-Release TabletsPresence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.Granules Pharmaceuticals Inc. · D-0192-2025Class IIOngoingJan 15, 2025Kit for the Preparation of Technetium Tc 99m Sulfur Colloid InjectionFailed Stability SpecificationsJubilant Draximage Inc., dba Jubilant Radiopharma · D-0191-2025Class IIOngoingJan 15, 2025Duloxetine DR Capsules USP 60 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0190-2025Class IIOngoingJan 15, 2025Duloxetine Delayed-Release Capsules USP 20 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0189-2025Class IIOngoingJan 15, 2025Duloxetine Delayed-Release Capsules USP 30 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0188-2025Class IITerminatedJan 15, 2025Colchicine Capsules 0.6 mgFailed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.Granules Pharmaceuticals Inc. · D-0187-2025Class IIOngoingJan 15, 2025Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.Eugia US LLC · D-0186-2025Class IIOngoingJan 15, 2025medroxyPROGESTERone Acetate Injectable SuspensionCGMP DeviationsEugia US LLC · D-0185-2025Class IIOngoingJan 15, 2025Clobazam TabletsPresence of Foreign Tablets/CapsulesAmerisource Health Services LLC · D-0184-2025Class IIIOngoingJan 15, 2025Methadone Hydrochloride TabletsFailed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.West-Ward Columbus Inc · D-0183-2025Class IIOngoingJan 15, 2025Ciprofloxacin Ophthalmic Solution USPDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottleFDC Limited · D-0182-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0181-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0180-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0179-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0178-2025Class IOngoingJan 15, 2025Nhan Sam Tuyet Lien Truy Phong HoanMarketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and ChlorpheniramineBuy-Herbal · D-0177-2025